[Clinical trial of a new broad-spectrum and long-acting antibacterial compound (2,4-dimethoxy-6-sulfanilamido-1,3-diazine)].
D000900:Anti-Bacterial Agents; D006571:Heterocyclic Compounds; D016219:Immunotherapy, Adoptive; D007239:Infections / Q000628:therapy*; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000628:therapy*
D000900:Anti-Bacterial Agents; D006571:Heterocyclic Compounds; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide
INFECTION/therapy; SULFONAMIDES/therapy